{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:04Z","timestamp":1794047464866,"version":"4.8.0"},"reference-count":59,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"7","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>t(1;19)(q23;p13) is one of the most common translocation genes in childhood acute lymphoblastic leukemia (ALL) and is also present in acute myeloid leukemia (AML) and mixed-phenotype acute leukemia (MPAL). This translocation results in the formation of the oncogenic E2A-PBX1 fusion protein, which contains a trans-activating domain from E2A and a DNA-binding homologous domain from PBX1. Despite its clear oncogenic potential, the pathogenesis of E2A-PBX1 fusion protein is not fully understood (especially in leukemias other than ALL), and effective targeted clinical therapies have not been developed. To address this, we established a stable and heritable zebrafish line expressing human E2A-PBX1 (hE2A-PBX1) for high-throughput drug screening. Blood phenotype analysis showed that hE2A-PBX1 expression induced myeloid hyperplasia by increasing myeloid differentiation propensity of hematopoietic stem cells (HSPC) and myeloid proliferation in larvae, and progressed to AML in adults. Mechanistic studies revealed that hE2A-PBX1 activated the TNF\/IL-17\/MAPK signaling pathway in blood cells and induced myeloid hyperplasia by upregulating the expression of runx1. Interestingly, through high-throughput drug screening, three small molecules targeting the TNF\/IL-17\/MAPK signaling pathway were identified, including OUL35, KJ-Pyr-9, and CID44216842, which not only alleviated the hE2A-PBX1-induced myeloid hyperplasia in zebrafish but also inhibited the growth and oncogenicity of human pre-B ALL cells with E2A-PBX1. Overall, this study provides a novel hE2APBX1 transgenic zebrafish leukemia model and identifies potential targeted therapeutic drugs, which may offer new insights into the treatment of E2A-PBX1 leukemia.<\/jats:p>","DOI":"10.3324\/haematol.2023.283647","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T04:31:04Z","timestamp":1708576264000},"page":"2092-2110","source":"Crossref","is-referenced-by-count":3,"title":["Targeting TNF\/IL-17\/MAPK pathway in h&lt;i&gt;E2A-PBX1&lt;\/i&gt; leukemia: effects of OUL35, KJ-Pyr-9, and CID44216842"],"prefix":"10.3324","volume":"109","author":[{"given":"Haiping","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"63022","doi-asserted-by":"crossref","unstructured":"Pi W-C, Wang J, Shimada M. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia. Blood. 2020; 136(1):11-23.","DOI":"10.1182\/blood.2019003312"},{"key":"63023","doi-asserted-by":"crossref","unstructured":"Duque-Afonso J, Lin CH, Han K. E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia. Cancer Res. 2016; 76(23):6937-6949.","DOI":"10.1158\/0008-5472.CAN-16-1899"},{"key":"63024","unstructured":"Amor Vigil AM, Fern\u00e1ndez Mart\u00ednez L, D\u00edaz Alonso CA. Transcripto E2A-PBX1 en paciente pedi\u00e1trico con leucemia aguda h\u00edbrida linfoide b\/mieloide. Rev Cubana Hematol Inmunol Hemoter. 2017; 33(3):95-101."},{"key":"63025","doi-asserted-by":"crossref","unstructured":"Troussard X, Rimokh R, Valensi F. Heterogeneity of t(1;19) (q23;p13) acute leukaemias. French Haematological Cytology Group. Br J Haematol. 1995; 89(3):516-526.","DOI":"10.1111\/j.1365-2141.1995.tb08357.x"},{"key":"63026","doi-asserted-by":"crossref","unstructured":"Hong Y, Zhao X, Qin Y. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2018; 97(9):1547-1554.","DOI":"10.1007\/s00277-018-3338-1"},{"key":"63027","doi-asserted-by":"crossref","unstructured":"Irving JAE, Enshaei A, Parker CA. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Blood. 2016; 128(7):911-922.","DOI":"10.1182\/blood-2016-03-704973"},{"key":"63028","doi-asserted-by":"crossref","unstructured":"Hunger SP. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood. 1996; 87(4):1211-1224.","DOI":"10.1182\/blood.V87.4.1211.bloodjournal8741211"},{"key":"63029","unstructured":"Zhao W, Li Z-g, Gao C. Detection of E2A\/PBX1 fusion gene and its clinical significance in childhood acute lymphoblastic leukemia. Zhonghua Er Ke Za Zhi. 2008; 46(7):550-551."},{"key":"63030","doi-asserted-by":"crossref","unstructured":"Jia M, Hu B-F, Xu X-J, Zhang J-Y, Li S-S, Tang Y-M. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: a single-center retrospective study of 837 patients from China. Curr Probl Cancer. 2021; 45(6):100758.","DOI":"10.1016\/j.currproblcancer.2021.100758"},{"key":"63031","doi-asserted-by":"crossref","unstructured":"Diakos C, Xiao Y, Zheng S, Kager L, Dworzak M, Wiemels JL. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein. PLoS One. 2014; 9(2):e87602.","DOI":"10.1371\/journal.pone.0087602"},{"key":"63032","doi-asserted-by":"crossref","unstructured":"Murre C. Regulation and function of the E2A proteins in B cell development. B Cell Biology. 2007;1-7.","DOI":"10.1007\/0-387-46530-8_1"},{"key":"63033","doi-asserted-by":"crossref","unstructured":"Semerad CL, Mercer EM, Inlay MA, Weissman IL, Murre C. E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors. Proc Natl Acad Sci U S A. 2009; 106(6):1930-1935.","DOI":"10.1073\/pnas.0808866106"},{"key":"63034","doi-asserted-by":"crossref","unstructured":"Malouf C, Ottersbach K. Molecular processes involved in B cell acute lymphoblastic leukaemia. Cell Mol Life Sci. 2018; 75(3):417-446.","DOI":"10.1007\/s00018-017-2620-z"},{"key":"63035","doi-asserted-by":"crossref","unstructured":"Aspland SE, Bendall HH, Murre C. The role of E2A-PBX1 in leukemogenesis. Oncogene. 2001; 20(40):5708-5717.","DOI":"10.1038\/sj.onc.1204592"},{"key":"63036","doi-asserted-by":"crossref","unstructured":"Kamps MP, Baltimore D. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol. 1993; 13(1):351-357.","DOI":"10.1128\/MCB.13.1.351"},{"key":"63037","unstructured":"Kamps MP, Wright DD. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene. 1994; 9(11):3159-3166."},{"key":"63038","doi-asserted-by":"crossref","unstructured":"Dedera DA, Waller EK, LeBrun DP. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 1993; 74(5):833-843.","DOI":"10.1016\/0092-8674(93)90463-Z"},{"key":"63039","doi-asserted-by":"crossref","unstructured":"Bijl J, Sauvageau M, Thompson A, Sauvageau G. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia. Genes Dev. 2005; 19(2):224-233.","DOI":"10.1101\/gad.1268505"},{"key":"63040","doi-asserted-by":"crossref","unstructured":"Sera Y, Yamasaki N, Oda H. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia. Cancer Sci. 2016; 107(7):890-898.","DOI":"10.1111\/cas.12945"},{"key":"63041","doi-asserted-by":"crossref","unstructured":"Sykes DB, Kamps MP. E2a\/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-t cells that cause acute T-lymphoid or myeloid leukemias in mice. Mol Cell Biol. 2004; 24(3):1256-1269.","DOI":"10.1128\/MCB.24.3.1256-1269.2004"},{"key":"63042","doi-asserted-by":"crossref","unstructured":"Hyndman BD, LeBrun DP. E2A-PBX1. 2009;935-936.","DOI":"10.1007\/978-3-540-47648-1_1785"},{"key":"63043","doi-asserted-by":"crossref","unstructured":"van de Ven C, Boeree A, Stalpers F, Zwaan CM, Den Boer ML. Ibrutinib is not an effective drug in primografts of TCF3-PBX1. Transl Oncol. 2020; 13(10):100817.","DOI":"10.1016\/j.tranon.2020.100817"},{"key":"63044","doi-asserted-by":"crossref","unstructured":"Eldfors S, Kuusanmaki H, Kontro M. Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia. Leukemia. 2017; 31(1):51-57.","DOI":"10.1038\/leu.2016.202"},{"key":"63045","doi-asserted-by":"crossref","unstructured":"Rasighaemi P, Basheer F, Liongue C, Ward AC. Zebrafish as a model for leukemia and other hematopoietic disorders. J Hematol Oncol. 2015; 8(1):1-10.","DOI":"10.1186\/s13045-015-0126-4"},{"key":"63046","doi-asserted-by":"crossref","unstructured":"Ali S, Champagne DL, Spaink HP, Richardson MK. Zebrafish embryos and larvae: a new generation of disease models and drug screens. Birth Defects Res C Embryo Today. 2011; 93(2):115-133.","DOI":"10.1002\/bdrc.20206"},{"key":"63047","doi-asserted-by":"crossref","unstructured":"Bentley VL, Veinotte CJ, Corkery DP. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica. 2015; 100(1):70-76.","DOI":"10.3324\/haematol.2014.110742"},{"key":"63048","doi-asserted-by":"crossref","unstructured":"Haney MG, Moore LH, Blackburn JS. Drug screening of primary patient derived tumor xenografts in zebrafish. J Vis Exp. 2020(158):10.","DOI":"10.3791\/60996-v"},{"key":"63049","doi-asserted-by":"crossref","unstructured":"Chauvign\u00e9 F, Yilmaz O, Ferr\u00e9 A. The vertebrate Aqp14 water channel is a neuropeptide-regulated polytransporter. Commun Biol. 2019; 2(1):462.","DOI":"10.1038\/s42003-019-0713-y"},{"key":"63050","doi-asserted-by":"crossref","unstructured":"Jin H, Sood R, Xu J. Definitive hematopoietic stem\/ progenitor cells manifest distinct differentiation output in the zebrafish VDA and PBI. Development. 2009; 136(4):647-654.","DOI":"10.1242\/dev.029637"},{"key":"63051","doi-asserted-by":"crossref","unstructured":"Jin H, Li L, Xu J. Runx1 regulates embryonic myeloid fate choice in zebrafish through a negative feedback loop inhibiting Pu.1 expression. Blood. 2012; 119(22):5239-5249.","DOI":"10.1182\/blood-2011-12-398362"},{"key":"63052","doi-asserted-by":"crossref","unstructured":"Pruvot B, Jacquel A, Droin N. Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica. 2011; 96(4):612-616.","DOI":"10.3324\/haematol.2010.031401"},{"key":"63053","doi-asserted-by":"crossref","unstructured":"Zeng Y, Zhang X, Lin D. A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia. J Hematol Oncol. 2021; 14(1):1-6.","DOI":"10.1186\/s13045-021-01199-8"},{"key":"63054","doi-asserted-by":"crossref","unstructured":"Khan N, Mahajan NK, Sinha P, Jayandharan GR. An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish. Blood Cells Mol Dis. 2019; 75:48-55.","DOI":"10.1016\/j.bcmd.2018.12.007"},{"key":"63055","doi-asserted-by":"crossref","unstructured":"Xu J, Du L, Wen Z. Myelopoiesis during zebrafish early development. J Genet Genomics. 2012; 39(9):435-442.","DOI":"10.1016\/j.jgg.2012.06.005"},{"key":"63056","doi-asserted-by":"crossref","unstructured":"LeBrun DP. E2A basic helix-loop-helix transcription factors in human leukemia. Front Biosci. 2003; 8:s206-s222.","DOI":"10.2741\/1030"},{"key":"63057","doi-asserted-by":"crossref","unstructured":"Baker WJ, Royer GL, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol. 1991; 9(4):679-693.","DOI":"10.1200\/JCO.1991.9.4.679"},{"key":"63058","unstructured":"Ota K. [Cytarabine]. Gan To Kagaku Ryoho. 1987; 14(10):2983-2987."},{"key":"63059","doi-asserted-by":"crossref","unstructured":"Magina KN, Pregartner G, Zebisch A. Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis. Blood. 2017; 130(7):946-948.","DOI":"10.1182\/blood-2017-04-777722"},{"key":"63060","doi-asserted-by":"crossref","unstructured":"Zeidner JF, Karp JE. Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia. Leuk Res. 2015; 39(12):1312-1318.","DOI":"10.1016\/j.leukres.2015.10.010"},{"key":"63061","doi-asserted-by":"crossref","unstructured":"Chen KTJ, Militao GGC, Anantha M, Witzigmann D, Leung AWY, Bally MB. Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia. J Control Release. 2021; 333:246-257.","DOI":"10.1016\/j.jconrel.2021.03.042"},{"key":"63062","doi-asserted-by":"crossref","unstructured":"Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. Blood. 2017; 129(15):2070-2082.","DOI":"10.1182\/blood-2016-10-687830"},{"key":"63063","doi-asserted-by":"crossref","unstructured":"Yan Z, Dai J, Wang J. RNF167-mediated ubiquitination of Tollip inhibits TNF-\u03b1-triggered NF-\u03baB and MAPK activation. FASEB J. 2023; 37(8):e23089.","DOI":"10.1096\/fj.202201839R"},{"key":"63064","doi-asserted-by":"crossref","unstructured":"Niu L, Fang Y, Yao X. TNF\u03b1 activates MAPK and Jak-Stat pathways to promote mouse Muller cell proliferation. Exp Eye Res. 2021; 202:108353.","DOI":"10.1016\/j.exer.2020.108353"},{"key":"63065","doi-asserted-by":"crossref","unstructured":"Sabio G, Davis RJ. TNF and MAP kinase signalling pathways. Semin Immunol. 2014; 26(3):237-245.","DOI":"10.1016\/j.smim.2014.02.009"},{"key":"63066","doi-asserted-by":"crossref","unstructured":"Aslani MR, Sharghi A, Boskabady MH. Altered gene expression levels of IL-17\/TRAF6\/MAPK\/USP25 axis and proinflammatory cytokine levels in lung tissue of obese ovalbuminsensitized rats. Life Sci. 2022; 296:120425.","DOI":"10.1016\/j.lfs.2022.120425"},{"key":"63067","doi-asserted-by":"crossref","unstructured":"Roussel L, Houle F, Chan C. IL-17 Promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol. 2010; 184(8):4531-4537.","DOI":"10.4049\/jimmunol.0903162"},{"key":"63068","doi-asserted-by":"crossref","unstructured":"Hata K, Andoh A, Shimada M. IL-17 stimulates inflammatory responses via NF-\u03baB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002; 282(6):G1035-G1044.","DOI":"10.1152\/ajpgi.00494.2001"},{"key":"63069","doi-asserted-by":"crossref","unstructured":"Sloan SR, Shen CP, McCarrick-Walmsley R, Kadesch T. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol Cell Biol. 1996; 16(12):6900-6908.","DOI":"10.1128\/MCB.16.12.6900"},{"key":"63070","doi-asserted-by":"crossref","unstructured":"Licht JD. Oncogenesis by E2A-PBX1 in ALL: RUNX and more. Blood. 2020; 136(1):3-4.","DOI":"10.1182\/blood.2020005879"},{"key":"63071","doi-asserted-by":"crossref","unstructured":"Huang A, Zhao H, Quan Y, Jin R, Feng B, Zheng M. E2A Predicts prognosis of colorectal cancer patients and regulates cancer cell growth by targeting miR-320a. Plos One. 2014; 9(1):e85201.","DOI":"10.1371\/journal.pone.0085201"},{"key":"63072","doi-asserted-by":"crossref","unstructured":"Xu W, Carr T, Ramirez K, McGregor S, Sigvardsson M, Kee BL. E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment. Blood. 2013; 121(9):1534-1542.","DOI":"10.1182\/blood-2012-08-449447"},{"key":"63073","doi-asserted-by":"crossref","unstructured":"Lu Q, Kamps MP. Selective repression of transcriptional activators by Pbx1 does not require the homeodomain. Proc Natl Acad Sci U S A. 1996; 93(1):470-474.","DOI":"10.1073\/pnas.93.1.470"},{"key":"63074","doi-asserted-by":"crossref","unstructured":"Mandal JP, Shiue C-N, Chen Y-C. PKC\u03b4 mediates mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression. Free Radic Biol Med. 2021; 163:69-87.","DOI":"10.1016\/j.freeradbiomed.2020.12.003"},{"key":"63075","doi-asserted-by":"crossref","unstructured":"Tian Y, Korn P, Tripathi P. The mono-ADP-ribosyltransferase ARTD10 regulates the voltage-gated ion channel Kv1.1 through protein kinase C delta. BMC Biol. 2020; 18(1):143.","DOI":"10.1186\/s12915-020-00878-1"},{"key":"63076","doi-asserted-by":"crossref","unstructured":"Murthy S, Desantis J, Verheugd P. 4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10\/ARTD10. Eur J Med Chem. 2018; 156:93-102.","DOI":"10.1016\/j.ejmech.2018.06.047"},{"key":"63077","doi-asserted-by":"crossref","unstructured":"Hart JR, Garner AL, Yu J. Inhibitor of MYC identified in a Krohnke pyridine library. Proc Natl Acad Sci U S A. 2014; 111(34):12556-12561.","DOI":"10.1073\/pnas.1319488111"},{"key":"63078","doi-asserted-by":"crossref","unstructured":"Lourenco C, Resetca D, Redel C. MYC protein interactors in gene transcription and cancer. Nat Rev Cancer. 2021; 21(9):579-591.","DOI":"10.1038\/s41568-021-00367-9"},{"key":"63079","doi-asserted-by":"crossref","unstructured":"Windmoeller BA, Beshay M, Helweg LP. Novel primary human cancer stem-like cell populations from non-small cell lung cancer: inhibition of cell survival by targeting NF-\u03baB and MYC signaling. Cells. 2021; 10(5):1024.","DOI":"10.3390\/cells10051024"},{"key":"63080","doi-asserted-by":"crossref","unstructured":"Hong L, Kenney SR, Phillips GK. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J Biol Chem. 2013; 288(12):8531-8543.","DOI":"10.1074\/jbc.M112.435941"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283647\/76619","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283647\/77164","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11456\/76619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:49Z","timestamp":1794045949000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283647","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,22]]}}}